Real-world results confirm benefit of antigen therapy for prostate cancer
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with ...
6 hours ago
0
2









